Vir Biotechnology, Inc. (VIR) Ownership

$7.31

south_east -$0.07 (-0.95%)
Day's range
$7.17
Day's range
$7.42

Vir Biotechnology, Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SB INVESTMENT ADVISERS (UK) LTD 11/14/2024 16.68 M $124.96 M   0.00% 12.21%
BLACKROCK FUNDING, INC. /DE 11/13/2024 16.38 M $122.65 M   100.00% 11.98%
VANGUARD GROUP INC 11/13/2024 13.14 M $98.39 M   2.23% 9.61%
STATE STREET CORP 11/14/2024 5.63 M $42.14 M   10.42% 4.12%
ORBIMED ADVISORS LLC 11/14/2024 3.57 M $26.76 M   54.00% 2.61%
BAILLIE GIFFORD & CO 11/05/2024 2.38 M $17.85 M   -39.23% 1.74%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2024 2.19 M $16.40 M   0.24% 1.60%
BILL & MELINDA GATES FOUNDATION 11/14/2024 1.56 M $11.68 M   0.00% 1.14%
MORGAN STANLEY 11/14/2024 1.24 M $9.26 M   -41.74% 0.91%
DIMENSIONAL FUND ADVISORS LP 11/07/2024 1.21 M $9.08 M   90.14% 0.89%
RENAISSANCE TECHNOLOGIES LLC 11/13/2024 1.18 M $8.86 M   -11.09% 0.87%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/12/2024 1.13 M $8.50 M   13.63% 0.83%
MILLENNIUM MANAGEMENT LLC 11/14/2024 1.10 M $8.27 M   -11.49% 0.81%
JPMORGAN CHASE & CO 11/08/2024 1.09 M $8.14 M   -13.46% 0.79%
JEFFERIES FINANCIAL GROUP INC. 11/14/2024 1.09 M $8.13 M   100.00% 0.79%
JEFFERIES FINANCIAL GROUP INC. 11/14/2024 1.09 M $8.13 M   100.00% 0.79%
VOLORIDGE INVESTMENT MANAGEMENT, LLC 11/14/2024 975,300 $7.30 M   -20.38% 0.71%
D. E. SHAW & CO., INC. 11/14/2024 930,655 $6.97 M   0.88% 0.68%
GOLDMAN SACHS GROUP INC 11/14/2024 832,683 $6.24 M   6.37% 0.61%
BANK OF NEW YORK MELLON CORP 11/12/2024 642,283 $4.81 M   -21.03% 0.47%
BARCLAYS PLC 11/19/2024 550,186 $4.12 M   1.34% 0.40%
HUDSON BAY CAPITAL MANAGEMENT LP 11/13/2024 528,242 $3.96 M   24.29% 0.39%
NUVEEN ASSET MANAGEMENT, LLC 11/14/2024 521,863 $3.91 M   141.37% 0.38%
PRINCIPAL FINANCIAL GROUP INC 10/31/2024 431,411 $3.23 M   -0.74% 0.32%
NORDEA INVESTMENT MANAGEMENT AB 11/05/2024 423,087 $3.24 M   53.55% 0.31%
INVESCO LTD. 11/12/2024 396,198 $2.97 M   -4.78% 0.29%
UBS GROUP AG 11/14/2024 383,188 $2.87 M   30.57% 0.28%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2024 358,086 $2.68 M   1,295.23% 0.26%
JACOBS LEVY EQUITY MANAGEMENT, INC 11/14/2024 350,265 $2.62 M   10.57% 0.26%
BANK OF AMERICA CORP /DE/ 11/14/2024 336,593 $2.52 M   -60.48% 0.25%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 11/14/2024 329,781 $2.47 M   -58.19% 0.24%
EMPOWERED FUNDS, LLC 11/06/2024 329,781 $2.47 M   -33.18% 0.24%
ADAR1 CAPITAL MANAGEMENT, LLC 11/14/2024 319,185 $2.39 M   190.17% 0.23%
CI PRIVATE WEALTH, LLC 11/12/2024 283,065 $2.12 M   6.38% 0.21%
TWO SIGMA INVESTMENTS, LP 11/14/2024 276,024 $2.07 M   -22.58% 0.20%
CITADEL ADVISORS LLC 11/14/2024 268,972 $2.01 M   -64.14% 0.20%
AMERIPRISE FINANCIAL INC 11/14/2024 267,414 $2.00 M   -13.28% 0.20%
LEGAL & GENERAL GROUP PLC 11/14/2024 258,936 $1.94 M   0.94% 0.19%
WELLS FARGO & COMPANY/MN 11/13/2024 251,757 $1.89 M   493.54% 0.18%
RHUMBLINE ADVISERS 11/12/2024 235,393 $1.76 M   -1.30% 0.17%
PDT PARTNERS, LLC 11/14/2024 220,821 $1.65 M   34.38% 0.16%
ALGERT GLOBAL LLC 11/12/2024 213,465 $1.60 M   27.95% 0.16%
AMERICAN CENTURY COMPANIES INC 11/12/2024 206,889 $1.55 M   22.98% 0.15%
TREXQUANT INVESTMENT LP 11/12/2024 196,991 $1.48 M   92.56% 0.14%
PUBLIC SECTOR PENSION INVESTMENT BOARD 11/14/2024 194,208 $1.45 M   1.36% 0.14%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 11/14/2024 189,670 $1.42 M   -13.46% 0.14%
SWISS NATIONAL BANK 11/07/2024 185,200 $1.39 M   0.00% 0.14%
CUBIST SYSTEMATIC STRATEGIES, LLC 11/14/2024 174,740 $1.31 M   -7.36% 0.13%
RAFFERTY ASSET MANAGEMENT, LLC 11/13/2024 173,852 $1.30 M   19.20% 0.13%
STATE OF ALASKA, DEPARTMENT OF REVENUE 10/24/2024 152,242 $1.14 M   0.74% 0.11%

Vir Biotechnology, Inc.institutional Ownership - FAQ's

Who are the largest shareholders of VIR shares?

During the previous two years, 255 institutional investors and hedge funds held shares of Vir Biotechnology, Inc.. The most heavily invested institutionals were:

SB INVESTMENT ADVISERS (UK) LTD: 16.68 M

BlackRock Funding, Inc. /DE: 16.38 M

VANGUARD GROUP INC: 13.14 M

STATE STREET CORP: 5.63 M

ORBIMED ADVISORS LLC: 3.57 M

BAILLIE GIFFORD & CO: 2.38 M

What percentage of Vir Biotechnology, Inc. stock is owned by institutional investors?

64.11% of Vir Biotechnology, Inc. stock is owned by institutional investors.

How much institutional buying is happening at VIR ?

Institutional investors have bought a total of 103.10 M shares in the last 24 months. This purchase volume represents approximately $753.68 M in transactions.